| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.009 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.01 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.01 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |